Previous 10 | Next 10 |
NASDAQ, TSX: NVCN VANCOUVER , June 27, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices fo...
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule Canada NewsWire VANCOUVER, June 25, 2019 NASDAQ, TSX: NVCN VANCOUVER , June 25, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally ...
NASDAQ, TSX: NVCN VANCOUVER , June 17, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the ...
Neovasc Announces Nasdaq Continuing to Monitor Minimum Market Value Deficiency Following 10 Consecutive Business Days Above US$35 Million Canada NewsWire VANCOUVER, June 7, 2019 NASDAQ, TSX: NVCN VANCOUVER , June 7, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "...
NASDAQ, TSX: NVCN VANCOUVER , June 4, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on June 4, 2019 in Vanco...
Neovasc Announces Publication of Peer-Reviewed Article in European Heart Journal Concluding Positive Cost-Effectiveness of the Neovasc Reducer™ Canada NewsWire VANCOUVER, May 28, 2019 NASDAQ, TSX: NVCN VANCOUVER , May 28, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or...
NASDAQ, TSX: NVCN VANCOUVER , May 23, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for...
Nano cap Neovasc (NASDAQ: NVCN ) is up 46% premarket on light volume in response to its announcement of two-year follow-up data on the Neovasc Reducer in 50 patients with refractory disabling angina (chest pain caused by reduced blood flow to the heart). The results were just p...
NASDAQ, TSX: NVCN VANCOUVER , May 22, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for...
Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million Canada NewsWire VANCOUVER, May 16, 2019 NASDAQ, TSX: NVCN VANCOUVER , May 16, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...